Announcements Trials
Browse Landscape

Phase

Phase 2 150Phase 1 69Phase 1/2 31Phase 3 14Phase NA 8Phase 4 7Phase EARLY_PHASE1 5Phase 2/3 5

Status

Recruiting 3Terminated 1Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Recurrence 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Dasatinib × Clear all
NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioma

NCT05432518 2025-04-25

Pilot Trial for Treatment of Recurrent Glioblastoma

AHS Cancer Control Alberta

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Glioblastoma, Recurrence

NCT04603872 2020-10-28

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Zhejiang University

Phase EARLY_PHASE1 Recruiting
120 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01482728 2016-05-13

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

University of Virginia

Phase EARLY_PHASE1 Completed
12 enrolled
Gynecologic

Endometrial Neoplasms

NCT00835679 2014-05-23

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Terminated
9 enrolled 3 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡